• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

23.01.2025
Ontology Is Sliding Towards $0.2000

Ontology (ONT) is down 2.3% this week, trading at $0.2176, in line with the broader crypto market where Bitcoin (BTC) has declined 2.0% to $101,632. While the new U.S. administration has made some strides toward fairer crypto regulation, Donald Trump has remained silent on the highly anticipated issue of adding Bitcoin to U.S. federal reserves.

Market speculation is rampant, with figures like BlackRock CEO Larry Fink suggesting Bitcoin could surge to $700,000 per coin if sovereign wealth funds begin accumulating. Other forecasts predict Bitcoin reaching $250,000 by year-end. While such projections could foster optimism, the lack of decisive action or announcements regarding U.S. crypto reserves is weighing heavily on the market.

For Ontology, the situation remains bearish. Having breached the critical support at $0.2500 last week, the token is now approaching the $0.2000 level. A failure to provide clear evidence or statements about U.S. federal crypto reserve plans could see ONT fall even further, breaching the $0.2000 mark and deepening its losses.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
EOS is Struggling at the Support at $0.5000

EOS has added 3.1% to $0.5879 this week, recovering from a low of $0.5242 on Monday, which was 7.1% lower. This recent rebound is bringing the price close to the critical support level at $0.5000, which could be crucial for future price movements.

The current price support is largely due to a broader market recovery rather than specific positive news about EOS itself. The token lost 27.0% in June, as investors grew increasingly disappointed with the lack of progress in the network's economic modernization promised by EOS founder Brendan Blumer. Any positive developments or announcements regarding these promised upgrades could push EOS prices above the $0.7000 resistance level.

4067
B
Adobe Got a Blue Sky ahead of $585 Target

We have discussed new Buy opportunities in Adobe just a few days ago, and now it surged from a $520-530 range $547.78 at June 28 close. It feels like the market is listening to us). The stock's price rose by more than 3.5% in one trading session and broke the resistance level at $535, which previously prevented Adobe from flying to the next sky levels, and now the major technical barrier has passed. Congratulations, as the way is clear until $585 at least, where the peaking price in mid-March was recorded. Hopefully, Adobe is now our new leader, which deserves testing $585 per share, as the first goal, which could be easily acceptable.

3338
Another Good Chance to Buy Merck

Merck share price partially used a fresh upside momentum to stop less than half of a dollar below the next $135 psychological resistance. U.S. Food and Drug Administration (FDA), which has approved KEYTRUDA, Merck’s anticancer drug (acting as an immune checkpoint inhibitor to help keeping T-cells from killing other cells) in combination with two other medications called carboplatin and paclitaxel, for the treatment of adult patients with primary advanced or recurrent endometrial carcinoma. It has been reported that KEYTRUDA plus carboplatin and paclitaxel followed by KEYTRUDA alone reduced the risk of disease progression or death by 40% for patients, whose cancer was mismatch repair proficient and by 70% for the group of patients, whose cancer was mismatch repair deficient when compared to placebo with carboplatin and paclitaxel followed by placebo alone.

Thus, this approval is based on data from the Phase 3 trial, being the third endometrial indication and the 40th indication overall for KEYTRUDA in North America. Hitting all-time peak at $134.62 on June 25 was followed by some further price retracement to nearly $127 during the next couple of trading sessions, which looks like a quite natural phenomenon on the market when the price just slightly exceeded the previous technical range. Yet, the bullish pressure quickly renewed, as soon as Merck price just started to bounce, so that it closed at as high as $129.82 on June 27. Any levels between $127 and $130 per share may represent another good chance to buy stocks by investing crowds, with only a tiny likelihood for the price to dive below $125.

We anticipated one more bullish stage in Merck stock since the beginning of the year, when the share price of the world's oldest pharmaceutical concern was hovering below $120. It has already moved to a higher price and now fundamental conditions are looking good for the next evolutionary transition path. So, every other technical call to action to buy Merck may lead its share price closer to Wall Street's analyst pool 12-month target, which is located at nearly $142.70, but may be easily moved to higher levels above $150 at least.

3240
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
ETC is Struggling to Reverse to the Upside

Ethereum Classic (ETC) is experiencing a rise of 2.4% this week, reaching $23.40. This increase comes after a dip of 6.0% to $21.49 on Monday. Currently, ETC is attempting to surpass the $25.00 support level. If a breakthrough above this level is successful, the token could resume its upward trend, targeting the $30.00 resistance.

A significant potential catalyst for ETC prices is the anticipated approval of a spot Ethereum-ETF by the U.S. Securities and Exchange Commission (SEC). Such approval could have a positive impact on ETC prices, contributing to a bullish momentum.

2671
120

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors